ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Abacavir Sulfate, Lamivudine And Zidovudine, and what generic alternatives are available?
Abacavir Sulfate, Lamivudine And Zidovudine is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
Summary for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Clinical Trials: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE at DailyMed |
Recent Clinical Trials for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gilead Sciences | Phase 3 |
Harvard School of Public Health | Phase 2 |
Harvard School of Public Health (HSPH) | Phase 2 |
See all ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE clinical trials
Pharmacology for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
Anatomical Therapeutic Chemical (ATC) Classes for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
US Patents and Regulatory Information for ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 202912-001 | Dec 5, 2013 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |